← Open Payments lookup

LAUREN DUFOUR: Open Payments

NPI 1508408477 · MANDEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,742 in 56 payments from 24 companies in 2025. Trend: 2023 $824 · 2024 $1,610 · 2025 $2,742

Food & beverage: $2,742
CompanyPaymentsAmount
Novo Nordisk Inc5$372
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$362
ABBVIE INC.4$276
Bayer Healthcare Pharmaceuticals Inc.5$180
AstraZeneca Pharmaceuticals LP3$159
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$149
Edwards Lifesciences Corporation1$142
Novartis Pharmaceuticals Corporation1$139
Actelion Pharmaceuticals US, Inc.1$122
Exact Sciences Corporation2$116

Products named: CAPLYTA, Wegovy, Kerendia, XIFAXAN, QULIPTA, LEQVIO, Ozempic, UPTRAVI.

Industry payments across LA — which companies pay providers there.